Xontogeny
Biotechnology · Venture Capital
1,137open roles in its portfolio
28investments
6exits
2016founded
Overview
Xontogeny is a life sciences accelerator and seed-stage investor that helps scientific founders and first-time CEOs build drug development companies. It provides seed and Series A funding together with hands-on strategic and operational support, investing alongside the Perceptive Xontogeny Venture Fund backed by Perceptive Advisors. The company was founded in 2016 by biotech executive Chris Garabedian and is based in Boston, Massachusetts.
Program
AcceleratorInvestments
28
17 of them startups
Hiring now
8
1,137 open roles
Exits
6
Focusshare of its companies
Health Care 71%Biotechnology 24%Financial Services 6%Artificial Intelligence 6%Sports 6%Gaming 6%
Where its companies are
United States 54%
Stage of its companies
Pre-seed & seed 100%
Its companies, the freshest money firstAll 28 investments
Galvanize Therapeutics® IncVenture round $96.1M · 16 mo ago · 8 roles
AdaptilensSeries A $17.5M · 2 yr ago
TORL BioTherapeutics LLCVenture round $158.3M · 2 yr ago
Delve BioVenture round $35M · 3 yr ago
Peroxitech Inc.Series A $25M · 3 yr ago
Tellus TherapeuticsVenture round $16M · 3 yr ago
VivoSenseSeries A $25M · 4 yr ago · 2 roles
AalphabioVenture round $20.3M · 5 yr ago · 5 roles
Forge BiologicsSeries B $120M · 5 yr ago · 13 roles
CereVasc eShunt® Device | Under Development for HydrocephalusVenture round $11.1M · 6 yr ago
AbbVieVenture round $60.3M · 7 yr ago · 1090 roles
Halozyme8 roles
Hiring fastestroles opened in 30 days
Co-investorscompanies they hold together
Similar investorstheir companies share markets and countries
Sources: its portfolio page, read Nov 3
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
361 Newbury Street, Suite 501, Boston, MA, 02115, US

RA Capital Management
Wellington Management
GV
Omega Funds
SR One
Atlas Venture
EcoR1 Capital
Foresite Capital
Longitude Capital
venBio Partners
OrbiMed